Replimune Group, Inc. - COMMON STOCK (REPL)

Historical Holders from Q3 2018 to Q3 2025

Symbol
REPL on Nasdaq
Type / Class
Equity / COMMON STOCK
Shares outstanding
78,365,632
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
82,882,156
Holdings value
$347,530,499
% of all portfolios
0%
Number of holders
160
Number of buys
96
Number of sells
-96
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Replimune Group, Inc. - COMMON STOCK (REPL)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BAKER BROS. ADVISORS LP 14.3% $99,960,291 11,045,336 Baker Bros. Advisors LP 07 Mar 2025
PRICE T ROWE ASSOCIATES INC /MD/ 10.6% $34,805,312 8,306,757 T. Rowe Price Associates, Inc. 30 Sep 2025
RTW INVESTMENTS, LP 8.2% $26,798,117 6,395,732 RTW Investments, LP 30 Sep 2025
Forbion Capital Fund III Cooperatief U.A. 6.1% $38,185,027 4,219,340 Forbion Capital Fund III Cooperatief U.A. 31 Dec 2024
Point72 Asset Management, L.P. 4.7% -17% $15,209,289 -$3,488,586 3,629,902 -19% Point72 Asset Management, L.P. 30 Sep 2025
VANGUARD GROUP INC 4.77% $32,542,424 3,595,848 The Vanguard Group 31 Dec 2024
Redmile Group, LLC 0.7% -95% $2,245,077 -$18,279,751 535,818 -89% Redmile Group, LLC 30 Sep 2025

Institutional Holders of Replimune Group, Inc. - COMMON STOCK (REPL)

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q3 82,882,156 $347,530,499 -$49,961,586 $4.19 160
2025 Q2 80,960,067 $752,124,138 -$9,722,609 $9.29 173
2025 Q1 81,976,905 $799,308,276 +$36,933,791 $9.75 165
2024 Q4 77,881,821 $943,217,348 +$80,774,805 $12.11 155
2024 Q3 69,947,896 $766,692,674 -$7,687,757 $10.96 143
2024 Q2 70,902,356 $638,102,295 +$37,351,096 $9 148
2024 Q1 67,014,350 $547,213,173 +$8,620,113 $8.17 147
2023 Q4 66,033,045 $556,812,735 -$40,625,538 $8.43 138
2023 Q3 56,812,005 $970,921,194 +$32,501,979 $17.11 126
2023 Q2 54,593,396 $1,267,069,422 +$26,630,495 $23.22 139
2023 Q1 53,816,654 $948,994,808 +$90,895,078 $17.66 138
2022 Q4 48,204,772 $1,310,877,449 +$189,427,869 $27.2 135
2022 Q3 40,775,249 $704,191,848 -$8,659,480 $17.27 103
2022 Q2 39,999,317 $700,208,199 +$17,983,844 $17.48 98
2022 Q1 39,119,622 $665,006,692 -$35,451,893 $16.98 104
2021 Q4 38,825,604 $1,050,822,879 +$5,595,187 $27.1 97
2021 Q3 35,350,579 $1,048,056,990 +$5,527,419 $29.64 99
2021 Q2 34,863,218 $1,338,855,937 -$5,476,278 $38.42 109
2021 Q1 34,665,378 $1,057,669,955 +$1,013,258 $30.51 106
2020 Q4 34,484,345 $1,315,869,430 +$362,197,042 $38.15 112
2020 Q3 26,602,669 $611,849,920 +$25,676,805 $23.02 78
2020 Q2 25,420,897 $630,933,046 +$87,691,348 $24.85 75
2020 Q1 22,171,093 $220,779,588 -$470,574 $9.97 56
2019 Q4 22,018,833 $315,719,677 +$48,171,940 $14.35 61
2019 Q3 18,572,485 $257,907,605 -$14,772,415 $13.9 51
2019 Q2 19,565,712 $286,574,644 +$6,757,973 $14.66 53
2019 Q1 19,131,429 $291,385,593 +$17,749,806 $15.22 53
2018 Q4 18,156,099 $181,563,000 +$1,489,969 $10 50
2018 Q3 17,925,571 $288,599,000 +$288,599,000 $16.1 54